Tumor spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences after limited resection for small Stage I lung adenocarcinomas

Journal of Thoracic Oncology

Volumn 10, Issue 5, 2015, Pages 806-814

  Kadota, Kyuichi ^a,b   Nitadori, Jun Ichi ^a,c   Sima, Camelia S ^a   Ujiie, Hideki ^a   Rizk, Nabil P ^a   Jones, David R ^a   Adusumilli, Prasad S ^a   Travis, William D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b KAGAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Adenocarcinoma; Invasion; Lung; Recurrence; Spread through air spaces

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LUNG ADENOCARCINOMA; LUNG LOBECTOMY; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; TUMOR INVASION; TUMOR SPREAD THROUGH AIR SPACE; ADENOCARCINOMA; BLOOD VESSEL; CANCER STAGING; LUNG ALVEOLUS; LUNG NEOPLASMS; LYMPH VESSEL; MIDDLE AGED; PATHOLOGY; PROCEDURES; SURVIVAL; TUMOR RECURRENCE;

ADENOCARCINOMA; AGED; BLOOD VESSELS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC VESSELS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PNEUMONECTOMY; PULMONARY ALVEOLI; RETROSPECTIVE STUDIES; SURVIVAL;

EID: 84938286585     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000486     Document Type: Article

References (37)

1. Travis WD, Brambilla E, Noguchi M, International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011 6 244 285
2. Kadota K, Suzuki K, Kachala SS, A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma. Mod Pathol 2012 25 1117 1127
3. Kadota K, Villena-Vargas J, Yoshizawa A, Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease. Am J Surg Pathol 2014 38 448 460
4. Kadota K, Yeh YC, Sima CS, The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: A conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype. Mod Pathol 2014 27 690 700
5. Kadota K, Yeh YC, D'Angelo SP, Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: Invasive mucinous pattern and extracellular mucin are associated with KRAS mutation. Am J Surg Pathol 2014 38 1118 1127
6. Kadota K, Nitadori J, Sarkaria IS, Thyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinoma. Cancer 2013 119 931 938
7. Nitadori J, Bograd AJ, Kadota K, Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2 cm or smaller. J Natl Cancer Inst 2013 105 1212 1220
8. Suzuki K, Kadota K, Sima CS, Clinical impact of immune microenvironment in stage I lung adenocarcinoma: Tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence. J Clin Oncol 2013 31 490 498
9. Sardari Nia P, Colpaert C, Vermeulen P, Different growth patterns of non-small cell lung cancer represent distinct biologic subtypes. Ann Thorac Surg 2008 85 395 405
10. Welter S, Jacobs J, Krbek T, Krebs B, Stamatis G, Long-term survival after repeated resection of pulmonary metastases from colorectal cancer. Ann Thorac Surg 2007 84 203 210
11. Shiono S, Ishii G, Nagai K, Histopathologic prognostic factors in resected colorectal lung metastases. Ann Thorac Surg 2005 79 278 282; discussion 283
12. Clayton F, Bronchioloalveolar carcinomas. Cell types, patterns of growth, and prognostic correlates. Cancer 1986 57 1555 1564
13. Edge SB, Byrd DR, Compton CC, American Joint Committee on Cancer Cancer Staging Manual 2009 7th Ed New York, NY Springer Pp. 253 270
14. Donington J, Ferguson M, Mazzone P, Thoracic Oncology Network of American College of Chest Physicians; Workforce on Evidence-Based Surgery of Society of Thoracic Surgeons American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer. Chest 2012 142 1620 1635
15. Tsutsumida H, Nomoto M, Goto M, A micropapillary pattern is predictive of a poor prognosis in lung adenocarcinoma, and reduced surfactant apoprotein A expression in the micropapillary pattern is an excellent indicator of a poor prognosis. Mod Pathol 2007 20 638 647
16. Miyoshi T, Satoh Y, Okumura S, Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am J Surg Pathol 2003 27 101 109
17. Onozato ML, Kovach AE, Yeap BY, Tumor islands in resected early-stage lung adenocarcinomas are associated with unique clinicopathologic and molecular characteristics and worse prognosis. Am J Surg Pathol 2013 37 287 294
18. Chappell R, Competing risk analyses: How are they different and why should you care? Clin Cancer Res 2012 18 2127 2129
19. Dignam JJ, Zhang Q, Kocherginsky M, The use and interpretation of competing risks regression models. Clin Cancer Res 2012 18 2301 2308
20. Gray RJ, A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988 16 1141 1154
21. Pezzella F, Pastorino U, Tagliabue E, Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol 1997 151 1417 1423
22. Onozato ML, Klepeis VE, Yagi Y, Mino-Kenudson M, A role of three-dimensional (3D) reconstruction in the classification of lung adenocarcinoma. Stud Health Technol Inform 2012 179 250 256
23. Meng X, Sun X, Mu D, Noninvasive evaluation of microscopic tumor extensions using standardized uptake value and metabolic tumor volume in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2012 82 960 966
24. Giraud P, Antoine M, Larrouy A, Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 2000 48 1015 1024
25. van Loon J, Siedschlag C, Stroom J, Microscopic disease extension in three dimensions for non-small-cell lung cancer: Development of a prediction model using pathology-validated positron emission tomography and computed tomography features. Int J Radiat Oncol Biol Phys 2012 82 448 456
26. Grills IS, Fitch DL, Goldstein NS, Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: Defining clinical target volume for radiotherapy. Int J Radiat Oncol Biol Phys 2007 69 334 341
27. Shiono S, Ishii G, Nagai K, Predictive factors for local recurrence of resected colorectal lung metastases. Ann Thorac Surg 2005 80 1040 1045
28. Raparia K, Ketterer J, Dalurzo ML, Chang YH, Colby TV, Leslie KO, Lung tumors masquerading as desquamative interstitial pneumonia (DIP): Report of 7 cases and review of the literature. Am J Surg Pathol 2014 38 921 924
29. Mutton AE, Hasleton PS, Curry A, Differentiation of desquamative interstitial pneumonia (DIP) from pulmonary adenocarcinoma by immunocytochemistry. Histopathology 1998 33 129 135
30. Okada M, Nishio W, Sakamoto T, Effect of tumor size on prognosis in patients with non-small cell lung cancer: The role of segmentectomy as a type of lesser resection. J Thorac Cardiovasc Surg 2005 129 87 93
31. Wisnivesky JP, Henschke CI, Swanson S, Limited resection for the treatment of patients with stage IA lung cancer. Ann Surg 2010 251 550 554
32. Kates M, Swanson S, Wisnivesky JP, Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: A review of SEER data. Chest 2011 139 491 496
33. National Lung Screening Trial Research Team Aberle DR, Adams AM, National Lung Screening Trial Research Team Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011 365 395 409
34. Aberle DR, Berg CD, Black WC, The national lung screening trial: Overview and study design. Radiology 2011 258 243 253
35. van Iersel CA, de Koning HJ, Draisma G, Risk-based selection from the general population in a screening trial: Selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007 120 868 874
36. Kamiya K, Hayashi Y, Douguchi J, Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma. Mod Pathol 2008 21 992 1001
37. Makimoto Y, Nabeshima K, Iwasaki H, Micropapillary pattern: A distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (